Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China
· Delayed Price · Currency is CNY 31.69
-0.35 (-1.09%)
Apr 30, 2026, 3:00 PM CST
SHA:600976 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,861 | 5,150 | 6,394 | 9,916 | 7,551 | 11,989 | Upgrade
|
| Market Cap Growth | -31.54% | -19.46% | -35.52% | 31.31% | -37.01% | 207.81% | Upgrade
|
| Enterprise Value | 3,850 | 4,163 | 5,531 | 9,131 | 6,672 | 11,258 | Upgrade
|
| Last Close Price | 31.69 | 33.57 | 40.80 | 62.52 | 46.90 | 73.07 | Upgrade
|
| PE Ratio | 14.41 | 14.31 | 17.65 | 19.02 | 18.50 | 39.27 | Upgrade
|
| Forward PE | - | 15.25 | 15.25 | 15.25 | 15.25 | 15.25 | Upgrade
|
| PS Ratio | 1.45 | 1.53 | 1.82 | 2.35 | 2.07 | 3.63 | Upgrade
|
| PB Ratio | 1.76 | 1.92 | 2.61 | 4.39 | 4.05 | 8.06 | Upgrade
|
| P/TBV Ratio | 1.79 | 1.96 | 2.66 | 4.47 | 4.13 | 8.28 | Upgrade
|
| P/FCF Ratio | 20.48 | 29.62 | 56.10 | 48.63 | 51.06 | 62.52 | Upgrade
|
| P/OCF Ratio | 14.08 | 18.76 | 27.29 | 36.95 | 34.98 | 48.36 | Upgrade
|
| EV/Sales Ratio | 1.15 | 1.24 | 1.58 | 2.17 | 1.83 | 3.41 | Upgrade
|
| EV/EBITDA Ratio | 14.67 | 15.88 | 37.78 | 26.38 | 22.62 | 47.72 | Upgrade
|
| EV/EBIT Ratio | 17.77 | 18.54 | 49.56 | 29.16 | 25.39 | 54.27 | Upgrade
|
| EV/FCF Ratio | 16.22 | 23.95 | 48.53 | 44.78 | 45.11 | 58.71 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.05 | 0.07 | 0.05 | 0.03 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.36 | 0.47 | 1.15 | 0.32 | 0.18 | 0.30 | Upgrade
|
| Debt / FCF Ratio | 0.40 | 0.72 | 1.54 | 0.56 | 0.36 | 0.37 | Upgrade
|
| Net Debt / Equity Ratio | -0.37 | -0.40 | -0.38 | -0.39 | -0.43 | -0.52 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.05 | -4.11 | -6.43 | -2.56 | -2.74 | -3.26 | Upgrade
|
| Net Debt / FCF Ratio | -4.35 | -6.20 | -8.26 | -4.34 | -5.46 | -4.01 | Upgrade
|
| Asset Turnover | 0.75 | 0.77 | 0.83 | 1.11 | 1.16 | 1.25 | Upgrade
|
| Inventory Turnover | 4.21 | 4.40 | 4.56 | 5.60 | 7.06 | 8.34 | Upgrade
|
| Quick Ratio | 1.28 | 1.36 | 1.20 | 1.18 | 1.16 | 1.17 | Upgrade
|
| Current Ratio | 1.55 | 1.58 | 1.49 | 1.49 | 1.50 | 1.41 | Upgrade
|
| Return on Equity (ROE) | 12.86% | 14.25% | 15.63% | 25.39% | 24.22% | 21.77% | Upgrade
|
| Return on Assets (ROA) | 3.02% | 3.19% | 1.65% | 5.14% | 5.22% | 4.92% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.24% | 13.50% | 7.26% | 23.62% | 27.42% | 25.02% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.50% | 8.00% | 4.40% | 13.50% | 13.80% | 13.50% | Upgrade
|
| Earnings Yield | 6.94% | 6.99% | 5.67% | 5.26% | 5.40% | 2.55% | Upgrade
|
| FCF Yield | 4.88% | 3.38% | 1.78% | 2.06% | 1.96% | 1.60% | Upgrade
|
| Dividend Yield | 2.81% | 2.68% | 2.21% | 1.92% | 2.13% | 1.10% | Upgrade
|
| Payout Ratio | 41.70% | 39.27% | 51.83% | 29.95% | 30.39% | 19.20% | Upgrade
|
| Buyback Yield / Dilution | -1.17% | 0.23% | 0.49% | -0.43% | -0.26% | 1.35% | Upgrade
|
| Total Shareholder Return | 1.67% | 2.91% | 2.69% | 1.49% | 1.87% | 2.45% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.